| 284690-33-1 | HUMAN LEUKOCYTE IFN |
| 284045-76-7 | Hexanedioic acid polymer with 1,4-butanediol, 1,6-diisocyanatohexane, 1,6-hexanediol, methyloxirane and oxirane | (C8H12N2O2.C6H14O2.C6H10O4.C4H10O2.C3H6O.C2H4O)x |
| 281659-95-8 | H-ARG-TRP-NH2 2 HCL | C17H25 N7 O2 . 2 Cl H |
| 281213-44-3 | H-TYR-LEU-NH2 HCL | C15H23 N3 O3 . Cl H |
| 274260-42-3 | H-D-LYS(ALLOC)-OH | C10H18 N2 O4 |
| 36394-07-7 | HEX-5-ENOYL CHLORIDE | C6H9 Cl O |
| 3673-41-4 | Hydrazinecarboxamide, N-2-thiazolyl- | C4H6 N4 O S |
| 36301-96-9 | H-ALA-PRO-GLY-OH | C10H17 N3 O4 |
| 272109-12-3 | Hexanenitrile, 2-methylene-5-oxo- (9CI) | C7H9 N O |
| 36077-41-5 | H-LEU-ILE-OH | C12H24 N2 O3 |
| 35978-98-4 | H-LYS-TYR-OH | C15H23 N3 O4 |
| 266340-65-2 | Hydrazinecarboxaldehyde, 2-(1,3,4-thiadiazol-2-yl)- (9CI) | C3H4 N4 O S |
| 265097-87-8 | Hexanedioic acid polymer with 5-amino-1,3,3-trimethylcyclohexane methanamine, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, methyloxirane, 3-methyl-1,5-pentanediol and oxirane | C39H74N4O10 |
| 264879-27-8 | Hexanedioic acid, polymer with 2-aminoethanol, N-(2-aminoethyl)-1,2-ethanediamine and (chloromethyl)oxirane | C15H35ClN4O6 |
| 263843-55-6 | H-ARG-ARG-AMC . 3HCL | C22H33 N9 O4 |
| 3557-90-2 | H-LYS(4-NITRO-Z)-OH | C14H19 N3 O6 |
| 3530-14-1 | Hydroxyacetic Acid Hydrazide | C2H6N2O2 |
| 3513-56-2 | H-ALA-BETANA HBR | C13H14 N2 O . Br H |
| 262856-90-6 | HEPTADECYL 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE | C25H49 N O6 |
| 262856-89-3 | HEPTADECYL 2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE | C31H55 N O9 |
| 262274-63-5 | Hydrazinecarboxylic acid, 2-[1-(methylamino)-2-nitroethenyl]-, methyl ester | C5H10 N4 O4 |
| 35655-79-9 | Heptafluorobutanol | C4H3 F7 O |
| 3415-08-5 | H-TYR-NCA | C10H9 N O4 |
| 35436-83-0 | H-DL-LEU-DL-VAL-OH H2O | C11H22 N2 O3 |
| 35401-46-8 | H-BETA-CHLORO-DL-ALA-OH HCL | C3H6 Cl N O2 . Cl H |
| 259870-74-1 | Hydrazinecarboxylic acid, 1-cyclopentyl-, 1,1-dimethylethyl ester (9CI) | C10H20 N2 O2 |
| 35369-53-0 | HBED HCL H2O | C20H24 N2 O6 . 2 Cl H |
| 35310-39-5 | H-PRO-TRP-OH | C16H19 N3 O3 |
| 257288-48-5 | H-D-CYS(FM)-OH | C17H17 N O2 S |
| 257288-19-0 | H-ARG(PBF)-OME HCL | C20H32 N4 O5 S . Cl H |
| 256663-95-3 | Hydrazinecarboxylic acid, (2-carboxy-1-methylethylidene)-, 1-(1,1- | C9H16 N2 O4 |
| 3365-67-1 | Hexacosanedioic acid | C26H50 O4 |
| 254866-44-9 | Hexokinase,from yeast |
| 253688-60-7 | Hydroxy Bosentan | C27H29N5O7S |
| 253596-70-2 | HEPT-2-EN-1-YLISOVALERATE | C12H22 O2 |
| 3350-15-0 | H-DAB(BOC)-OME HCL | C10H20 N2 O4 . Cl H |
| 3325-10-8 | hydrogen 5,6-dichloro-2-[3-[5,6-dichloro-1-ethyl-1,3-dihydro-3-(3-sulphonatobutyl)-2H-benzimidazol-2-ylidene]propen-1-yl]-1-ethyl-3-(3-sulphonatobutyl)-1H-benzimidazolium | C29H34 Cl4 N4 O6 S2 |
| 3314-13-4 | Hydrazine, (1-phenylpropyl)- | C9H14 N2 |
| 35166-54-2 | H-HIS-OET 2HCL | C8H15Cl2N3O2 |
| 3313-39-1 | H-ASN-BETANA | C14H15 N3 O2 |
| 35023-55-3 | H-L-MEALA-OME HCL | C5H11 N O2 |
| 252561-94-7 | HYDRAZINE,[4-(METHYLSULFONYL)-3-(TRIFLUOROMETHYL)PHENYL] | C8H9 F3 N2 O2 S |
| 252561-93-6 | HYDRAZINE,[4-(METHYLSULFONYL)-3-(TRIFLUOROMETHYL)PHENYL]-,MONOHYDROCHLORIDE | C8H9 F3 N2 O2 S . Cl H |
| 3190-71-4 | H-GLU(OBZL)-NCA | C13H13 N O5 |
| 250156-57-1 | Hexanedinitrile, hydrogenated, low-boiling fraction, polymer with epichlorohydrin, acetates (salts) |
| 34783-31-8 | Hydroxydehydro Nifedipine Carboxylate | C16H14 N2 O7 |
| 247142-89-8 | Hydroxylamine, O-[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]- (9CI) | C10H21 N O |
| 3178-39-0 | Hydrazine, (1-methyl-1-phenylethyl)- | C9H14 N2 |
| 34557-94-3 | Hexanedioic acid, polymer with 1,3-diisocyanato-2-methylbenzene, 2,4-diisocyanato-1-methylbenzene, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol and 2,2'-oxybis[ethanol] | C34H46N4O14 |
| 245329-88-8 | Hexadecanamide, N-[(1R,2R)-2-(4-chlorophenyl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]- | C29H49 Cl N2 O2 |
| 245329-80-0 | Hexadecanamide, N-[(1R,2R)-2-(1,3-benzodioxol-5-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]- | C30H50 N2 O4 |
| 245329-79-7 | Hexadecanamide, N-[(1R,2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl] | C32H54 N2 O4 |
| 245329-77-5 | Hexadecanamide, N-[(1R,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-(1-pyrrolidinylmethyl)ethyl]- | C29H50 N2 O3 |
| 245089-42-3 | Hexanedioic acid polymer with 1,3-diisocyanatomethyl benzene, α-hydro-ω-hydroxypoly(oxy-1,4-butanediyl), α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl) and 3-(2-propenyloxy)-1,2-propanediol |
| 244765-93-3 | H-Arg-His-NH2 | C12H22 N8 O2 |
| 34459-26-2 | hexoprenaline sulfate | C22H34N2O10S |
| 244082-19-7 | H-Cys-Thr-Thr-His-Trp-Gly-Phe-Thr-Leu-Cys-OH, (Disulfide bond) | C52H71 N13 O14 S2 |
| 243982-96-9 | HYDROXYETHYL CETEARAMIDOPROPYLDIMONIUM CHLORIDE | C32H60Cl2NO2 |
| 34367-76-5 | H-ARG-GLY-NH2 SULFATE | C8H18 N6 O2 |
| 34367-73-2 | H-ARG-GLY-PHE-PHE-OH | C26H35 N7 O5 |
| 243466-39-9 | H-ARG-GLN-ARG-ARG-AMC TRIFLUOROACETATE SALT | C33H53 N15 O7 |
| 34327-70-3 | H-ALA-PHE-PRO-OH | C17H23 N3 O4 |
| 34273-12-6 | H-ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-OH | C56H78 N16 O13 |
| 34229-60-2 | Hexanedioic acid, polymer with 1,4-butanediol, 1,1-methylenebis4-isocyanatobenzene and 1,2-propanediol | (C15H10N2O2.C6H10O4.C4H10O2.C3H8O2)x |
| 34176-76-6 | Hexanoic acid, 6-bromo-, trimethylsilyl ester | C9H19 Br O2 Si |
| 3062-07-5 | H-VAL-GLU-OH | C10H18 N2 O5 |
| 3061-96-9 | H-MET-ALA-OH FORMATE | C8H16 N2 O3 S |
| 3061-91-4 | H-VAL-TYR-OH | C14H20 N2 O4 |
| 33917-71-4 | HYPOXANTHINE-[2,8-3H] | C5H2 N4 O T2 |
| 233677-84-4 | Hydroxylamine, N-hydroxy-O-(tetrahydro-4-methoxy-2H-pyran-4-yl)- (9CI) | C6H13 N O4 |
| 233666-04-1 | HEX-3-ENYL2-ETHYLBUTYRATE | C12H22 O2 |
| 233666-03-0 | HEX-3-ENYLHEXADECANOATE | C22H42 O2 |
| 233666-01-8 | HEPT-4-ENYL-2BUTYRATE | C11H20 O2 |
| 232257-97-5 | HEPTADECANOIC ACID TRYPTAMIDE | C27H44 N2 O |
| 229321-94-2 | Hydrazinecarboxamide, N-[3-(dimethylamino)propyl]- | C6H16 N4 O |
| 33701-74-5 | Hexafluoro-2-propylalcohol | C24H18 O12 |
| 228850-37-1 | Hexadecanoic acid, (1R)-1-hydroxy2-9-(O-.alpha.-D-mannopyranosyl-(1?3)-O-.alpha.-D-mannopyranosyl-(1?6)-.alpha.-D-mannopyranosyl)oxy-1-oxononylaminoethoxyphosphinyloxymethyl-1,2-ethanediyl ester, monosodium salt | C64H121NNaO25P |
| 228850-36-0 | Hexadecanoic acid, (1R)-1-hydroxy2-9-(.alpha.-D-mannopyranosyloxy)-1-oxononylaminoethoxyphosphinyloxymethyl-1,2-ethanediyl ester, monosodium salt | C52H100 N O15 P . Na |
| 227945-81-5 | human normal immunoglobulin |
| 33605-56-0 | H-D-3,4-DMP-OH | C11H15 N O4 |
| 226957-08-0 | Hydrazinecarboxylic acid, 2-(1-oxobutyl)-, 1,1-dimethylethyl ester (9CI) | C9H18 N2 O3 |
| 33529-85-0 | H-VAL-NH2 HBR | C5H12 N2 O . Br H |
| 33528-35-7 | HEXANE-2,5-DIONE MONOETHYLENEKETAL | C8H14 O3 |
| 225234-03-7 | HIPPOPHAE RHAMNOIDES OIL |
| 378-34-7 | HEPTAFLUOROISOPROPYLBENZENE 98 | C9H5 F7 |
| 375-13-3 | HEPTAFLUOROBUTANOYL BROMIDE | C4Br F7 O |
| 223911-98-6 | HOLMIUM BROMIDE HYDRATE 99.999% | Br3Ho . x H2 O |
| 223602-78-6 | Heptanoic acid, 5,6-diamino- | C7H16 N2 O2 |
| 33208-98-9 | H-PRO-NHCH3 HCL | C6H12 N2 O . Cl H |
| 33086-66-7 | HYDROXYISOPROPYLCYCLOPENTADIENYLMANGANE& | C11H11 Mn O4 |
| 221243-01-2 | HOMO-L-TYROSINE HBR | C10H13 N O3 |
| 220828-91-1 | HYDROXYETHYL BEHENAMIDOPROPYL DIMONIUM CHLORIDE | C29H61 N2 O2 . Cl |
| 220789-22-0 | Homoserine, N-(6,9-dihydro-6-oxo-9--bta--D-ribofuranosyl-1H-purin-2-yl)- (9CI) | C14H19 N5 O8 |
| 33012-50-9 | HEPTA-O-ACETYL-BETA-MALTOSYL AZIDE | C6H6 N2 O3 |
| 33012-49-6 | HEPTA-O-ACETYL-SS-MALTOSYL AZIDE | C26H35 N3 O17 |
| 32537-59-0 | HEXAHYDRO-1H-AZEPINE-2-ETHANOL | C8H17 N O |
| 32524-23-5 | hexoprenaline sulfate | C22H34N2O10S |
| 32524-21-3 | hexoprenaline sulfate | C22H34N2O10S |
| 32517-10-5 | Hexanedioic acid, polymer with 1,4-butanediol, 1,1-methylenebis4-isocyanatobenzene and 2,2-oxybisethanol | (C15H10N2O2.C6H10O4.C4H10O3.C4H10O2)x |
| 32489-67-1 | hexoprenaline | C22H32 N2 O6 |